You have 9 free searches left this month | for more free features.

Astrocytoma

Showing 26 - 50 of 748

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Astrocytoma, Oligodendroglioma, Adult, Glioma, Malignant Trial in Saint Louis (temporally-modulated pulsed radiotherapy (TMPRT))

Recruiting
  • Astrocytoma
  • +2 more
  • temporally-modulated pulsed radiotherapy (TMPRT)
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 19, 2023

Recurrent Glioblastoma, Recurrent Astrocytoma, Recurrent Oligodendroglioma Trial in Oklahoma City (Niraparib)

Recruiting
  • Recurrent Glioblastoma
  • +3 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Jul 20, 2022

Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

Active, not recruiting
  • Glioma, Malignant
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

Glioblastoma Multiforme of Brain, Anaplastic Astrocytoma of Brain, Gliosarcoma of Brain Trial in Birmingham (C134)

Active, not recruiting
  • Glioblastoma Multiforme of Brain
  • +2 more
  • C134
  • Birmingham, Alabama
    University of Alabama at Birmingham
Sep 19, 2022

Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Astrocytoma, Grade IV Trial in Ann Arbor (drug, radiation, procedure)

Recruiting
  • Recurrent Glioblastoma
  • +5 more
  • Mycophenolate Mofetil
  • +3 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jul 7, 2022

Anaplastic Astrocytoma, IDH-Wildtype, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma Trial in Houston (other,

Recruiting
  • Anaplastic Astrocytoma, IDH-Wildtype
  • +8 more
  • Quality-of-Life Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 8, 2022

Glioma, Pilocytic Astrocytoma, Anaplastic Astrocytoma Trial in Saint Louis (MRI-guided laser ablation, Doxorubicin, Etoposide)

Recruiting
  • Glioma
  • +8 more
  • MRI-guided laser ablation
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 22, 2022

Astrocytoma Trial (Vorasidenib, Pembrolizumab)

Not yet recruiting
  • Astrocytoma
  • (no location specified)
Aug 1, 2022

High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)

Not yet recruiting
  • High-grade Glioma
  • +3 more
  • Low-dose OKN-007, BID
  • +3 more
  • (no location specified)
Sep 26, 2022

Loupe-Based Intraoperative Fluorescence Imaging

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
    • Lexington, Kentucky
      University of Kentucky
    Mar 3, 2022

    Glioma, IDH Mutation, Astrocytoma Trial in Philadelphia (Retifanlimab, All-trans retinoic acid)

    Not yet recruiting
    • Glioma
    • +3 more
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Jul 22, 2022

    Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype, Astrocytoma, Grade III Trial in San Antonio, Zuerich (Debio 0123,

    Not yet recruiting
    • Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype
    • Astrocytoma, Grade III
    • Debio 0123
    • +2 more
    • San Antonio, Texas
    • +1 more
    Mar 9, 2023

    Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

    Completed
    • Malignant Glioma
    • +3 more
    • Dendritic Cell Vaccine
    • +3 more
    • Miami, Florida
      University of Miami
    Jul 19, 2022

    Oligodendroglioma, Astrocytoma, Grade II, Glioma, Astrocytic Trial in San Francisco (GBM6-AD and poly-ICLC before and after

    Active, not recruiting
    • Oligodendroglioma
    • +5 more
    • GBM6-AD and poly-ICLC before and after surgery
    • GBM6-AD and poly-ICLC after surgery only
    • San Francisco, California
      University of California
    Sep 20, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

    Terminated
    • Glioblastoma Multiforme
    • +3 more
    • Indianapolis, Indiana
      Riley Hospital for Children at IU Health
    Jul 21, 2022

    Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma Trial in Rochester (procedure,

    Active, not recruiting
    • Adult Anaplastic Astrocytoma
    • +15 more
    • biopsy
    • +7 more
    • Rochester, Minnesota
      Mayo Clinic
    Apr 8, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

    Suspended
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • Bevacizumab and Carboplatin
    • New York, New York
      Lenox Hill Brain Tumor Center
    Oct 27, 2021

    Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,

    Recruiting
    • Glioblastoma
    • +3 more
    • Nivolumab-Placebo
    • +4 more
    • Los Angeles, California
    • +3 more
    Jan 16, 2023

    Glioblastomas, Sarcoma, Astrocytoma Trial run by the NCI (Enhanced Mindfulness Intervention, Psychoeducation)

    Completed
    • Glioblastomas
    • +4 more
    • Enhanced Mindfulness Intervention
    • Psychoeducation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Sep 14, 2022

    Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

    Recruiting
    • Astrocytoma
    • +22 more
    • Kogarah, New South Wales, Australia
    • +1 more
    Apr 18, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Recurrent Glioblastoma Trial in Portland (TVI-Brain 1)

    Available
    • Recurrent Glioblastoma
    • TVI-Brain 1
    • Portland, Oregon
      Providence St. Vincent Medical Center
    Jun 28, 2023

    Glioblastoma, Astrocytoma, Grade III, Astrocytoma, Grade IV Trial in Lake Success (Stereotactic Radiosurgery)

    Active, not recruiting
    • Glioblastoma
    • +3 more
    • Stereotactic Radiosurgery
    • Lake Success, New York
      Northwell Health Brain Tumor Center
    Feb 3, 2022

    Recurrent Glioblastoma Multiforme, Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma or Gliosarcoma Trial in

    Active, not recruiting
    • Recurrent Glioblastoma Multiforme
    • +2 more
    • M032 (NSC 733972)
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 26, 2022